Deferoxamine mesylate
Deferoxamine Mesylate for Injection, USPVialsRx onlyPrescribing Information
Approved
Approval ID
72348776-4971-bc49-8b66-67a2422567d4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 23, 2018
Manufacturers
FDA
ApoPharma USA, Inc.
DUNS: 962810821
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code52609-4504
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateOctober 7, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 2 g in 1 1
Code: V9TKO7EO6K
Classification: ACTIB
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code52609-4505
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateOctober 7, 2017
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 500 mg in 1 1
Code: V9TKO7EO6K
Classification: ACTIB